Literature DB >> 1489631

Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

N Tamaki1, Y Magata, N Takahashi, M Kawamoto, T Torizuka, Y Yonekura, S Nishizawa, N Sadato, E Tadamura, S Ono.   

Abstract

Experimental studies indicated the clearance rate constant of 11C-acetate as an index of regional myocardial oxygen consumption. To assess the response of the clearance rate from the left ventricular (LV) myocardium to the change in plasma substrate levels and to the increase in the cardiac work load in normal subjects, a total of 18 dynamic positron emission tomographic studies were performed at rest in the fasting state (control) (n = 7), after oral glucose administration (n = 4), and during dobutamine infusion (n = 7) in 7 normal volunteers. The clearance rate constant (Kmono) was similar in the control (0.065 +/- 0.017 min-1) and glucose loading states (0.059 +/- 0.008 min-1), whereas a significant increase in Kmono was observed during dobutamine infusion (0.106 +/- 0.018 min-1) (p < 0.01) in relation to the increase in the pressure-rate product with a correlation coefficient of 0.873 (p < 0.01). When the LV myocardium was divided into 6 segments, there were no significant differences among the segments in Kmono values in any condition. These normal responses should be valuable for assessing oxidative metabolic reserve and regional changes in oxidative metabolism in patients with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489631     DOI: 10.1007/bf03164658

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  32 in total

1.  Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.

Authors:  N Tamaki; M Kawamoto; N Takahashi; Y Yonekura; Y Magata; R Nohara; H Kambara; C Kawai; J Konishi
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

2.  Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.

Authors:  S L Meyer; G C Curry; M S Donsky; D B Twieg; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1976-07       Impact factor: 2.778

3.  Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.

Authors:  M Grover-McKay; H R Schelbert; M Schwaiger; H Sochor; P M Guzy; J Krivokapich; J S Child; M E Phelps
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

4.  C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium.

Authors:  H R Schön; H R Schelbert; G Robinson; A Najafi; S C Huang; H Hansen; J Barrio; D E Kuhl; M E Phelps
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

Review 5.  Emission tomography of the heart.

Authors:  H R Schelbert; E Henze; M E Phelps
Journal:  Semin Nucl Med       Date:  1980-10       Impact factor: 4.446

6.  Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.

Authors:  M Brown; D R Marshall; B E Sobel; S R Bergmann
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

Review 7.  Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing.

Authors:  H G Stratmann; H L Kennedy
Journal:  Am Heart J       Date:  1989-06       Impact factor: 4.749

8.  Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.

Authors:  M A Brown; D W Myears; S R Bergmann
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

9.  Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion.

Authors:  C Berthe; L A Pierard; M Hiernaux; G Trotteur; P Lempereur; J Carlier; H E Kulbertus
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

10.  The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.

Authors:  J J Berry; J A Baker; K S Pieper; M W Hanson; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

View more
  7 in total

1.  Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis: assessment using 11C-acetate positron emission tomography.

Authors:  Masanao Naya; Satoru Chiba; Hiroyuki Iwano; Satoshi Yamada; Chietsugu Katoh; Osamu Manabe; Keiichiro Yoshinaga; Yoshiro Matsui; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

2.  Feasibility of planar myocardial carbon 11-acetate imaging.

Authors:  L J Klein; F C Visser; S A Nurmohamed; A Vink; J H Peters; P Knaapen; P S Kruijer; J D Herscheid; G J Teule; C A Visser
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

Review 3.  Current status of viability assessment with positron tomography.

Authors:  N Tamaki
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 4.  Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT.

Authors:  N Tamaki; Y Fujibayashi; Y Magata; Y Yonekura; J Konishi
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

Review 5.  Metabolic imaging using PET.

Authors:  Takashi Kudo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-05       Impact factor: 9.236

Review 6.  Imaging of Myocardial Oxidative Metabolism in Heart Failure.

Authors:  Masanao Naya; Nagara Tamaki
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014

7.  Radiopharmaceutical tracers for cardiac imaging.

Authors:  Osamu Manabe; Tatsuya Kikuchi; Arthur J H A Scholte; Mohammed El Mahdiui; Ryuichi Nishii; Ming-Rong Zhang; Eriko Suzuki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2017-12-01       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.